Theravance Biopharma, Inc.
TBPH
|
$9.16
-0.65%
-0.66%
300K
|
Health Technology
(0.0% 1d) (4.0% 1m) (-17.3% 1y) (0.0% 2d) (-0.5% 3d) (-1.8% 7d) (-11.45% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 444,809,188
http://www.theravance.com
Sec Filling | Patents | 316 employees
(KY) Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
brands msa
add to watch list Paper trade email alert is off
Press-releases
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
Published: 2024-04-10 (Crawled : 10:00) - prnewswire.com
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: -1.37%
H: 2.14%
C: 2.03%
treatment system for key potential
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy on May 23, 2024
Published: 2024-04-10 (Crawled : 11:00) - biospace.com/
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: -1.37%
H: 2.14%
C: 2.03%
treatment system for key potential
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-02-26 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 0.9%
H: 0.0%
C: 0.0%
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: 0.65%
H: 8.83%
C: 4.31%
business year update financial results
Theravance Biopharma to Participate in an Upcoming Investor Conference
Published: 2024-02-22 (Crawled : 11:00) - prnewswire.com
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: -0.57%
H: 0.92%
C: -0.4%
conference biopharma
Theravance Biopharma to Participate in an Upcoming March 2024 Investor Conference
Published: 2024-02-22 (Crawled : 12:00) - biospace.com/
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: -0.57%
H: 0.92%
C: -0.4%
conference biopharma
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
Published: 2024-02-14 (Crawled : 11:00) - prnewswire.com
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: 1.2%
H: 0.47%
C: 0.12%
report year biopharma financial results
Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Published: 2024-01-05 (Crawled : 11:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.0%
H: 4.59%
C: 3.72%
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: -11.02%
H: 6.05%
C: 1.17%
yupelri disease biopharma results study
Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
Published: 2023-12-21 (Crawled : 22:00) - prnewswire.com
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: 1.32%
H: 0.78%
C: -3.83%
grant
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference
Published: 2023-12-18 (Crawled : 11:00) - prnewswire.com
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
|
| O: -0.91%
H: 3.12%
C: 2.57%
conference biopharma
Viatris Shareholders Re-elect All Nominated Directors and Approve All Voting Matters at Annual Meeting of Shareholders
Published: 2023-12-15 (Crawled : 21:00) - prnewswire.com
TBPH | $9.16 -0.65% -0.66% 300K
|
Health Technology
| Email alert
Add to watchlist
GNW | $6.0 -1.64% -0.33% 3.6M
|
Finance
| Email alert
Add to watchlist
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
| Email alert
Add to watchlist
meeting
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10